BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7543776)

  • 1. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population.
    DiBrino M; Parker KC; Margulies DH; Shiloach J; Turner RV; Biddison WE; Coligan JE
    Biochemistry; 1995 Aug; 34(32):10130-8. PubMed ID: 7543776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues.
    DiBrino M; Parker KC; Margulies DH; Shiloach J; Turner RV; Biddison WE; Coligan JE
    J Biol Chem; 1994 Dec; 269(51):32426-34. PubMed ID: 7528217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex.
    Macdonald W; Williams DS; Clements CS; Gorman JJ; Kjer-Nielsen L; Brooks AG; McCluskey J; Rossjohn J; Purcell AW
    FEBS Lett; 2002 Sep; 527(1-3):27-32. PubMed ID: 12220628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.
    Herman J; Jongeneel V; Kuznetsov D; Coulie PG
    Tissue Antigens; 1999 Feb; 53(2):111-21. PubMed ID: 10090611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain.
    Fleischhauer K; Avila D; Vilbois F; Traversari C; Bordignon C; Wallny HJ
    Tissue Antigens; 1994 Nov; 44(5):311-7. PubMed ID: 7878657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Position 45 influences the peptide binding motif of HLA-B*44:08.
    Badrinath S; Huyton T; Schumacher H; Blasczyk R; Bade-Doeding C
    Immunogenetics; 2012 Mar; 64(3):245-9. PubMed ID: 22009320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
    Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
    J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.
    Luescher IF; Romero P; Kuznetsov D; Rimoldi D; Coulie P; Cerottini JC; Jongeneel CV
    J Biol Chem; 1996 May; 271(21):12463-71. PubMed ID: 8647853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
    DiBrino M; Parker KC; Shiloach J; Turner RV; Tsuchida T; Garfield M; Biddison WE; Coligan JE
    J Immunol; 1994 Jan; 152(2):620-31. PubMed ID: 7506728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides.
    DiBrino M; Parker KC; Shiloach J; Knierman M; Lukszo J; Turner RV; Biddison WE; Coligan JE
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1508-12. PubMed ID: 7679507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
    Theodossis A; Guillonneau C; Welland A; Ely LK; Clements CS; Williamson NA; Webb AI; Wilce JA; Mulder RJ; Dunstone MA; Doherty PC; McCluskey J; Purcell AW; Turner SJ; Rossjohn J
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5534-9. PubMed ID: 20212169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06.
    Eichmann M; de Ru A; van Veelen PA; Peakman M; Kronenberg-Versteeg D
    Tissue Antigens; 2014 Oct; 84(4):378-88. PubMed ID: 25154780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.
    Herman J; van der Bruggen P; Luescher IF; Mandruzzato S; Romero P; Thonnard J; Fleischhauer K; Boon T; Coulie PG
    Immunogenetics; 1996; 43(6):377-83. PubMed ID: 8606058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3.
    Fleischhauer K; Fruci D; Van Endert P; Herman J; Tanzarella S; Wallny HJ; Coulie P; Bordignon C; Traversari C
    Int J Cancer; 1996 Nov; 68(5):622-8. PubMed ID: 8938145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
    Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
    J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
    Griffin TA; Yuan J; Friede T; Stevanovic S; Ariyoshi K; Rowland-Jones SL; Rammensee HG; Colbert RA
    J Immunol; 1997 Nov; 159(10):4887-97. PubMed ID: 9366414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico analysis of peptide binding features of HLA-B*4006.
    Gadewal NS; Joshi NN
    Indian J Exp Biol; 2012 Feb; 50(2):93-100. PubMed ID: 22670471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding.
    Parker KC; Biddison WE; Coligan JE
    Biochemistry; 1994 Jun; 33(24):7736-43. PubMed ID: 8011638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09.
    Huyton T; Schumacher H; Blasczyk R; Bade-Doeding C
    Immunogenetics; 2012 Sep; 64(9):663-8. PubMed ID: 22706990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.